Skip to content

Lartruvo – patient leaflet, side effects, dosage

Contains active substance:: Olaratumab
ATC code:: L01XC27 olaratumab
Similar medicines:: Oyavas

Darzalex

Herzuma

Removab

Mvasi

Riximyo

Arzerra

Blenrep

Kanjinti

MabThera

Rituzena (previously Tuxella)

Onbevzi

Patient leaflet - Lartruvo

Sources: Original PDF (ema.europa.eu)

The drug is classified in the ATC tree:

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01X Other antineoplastic agents

L01XC Monoclonal antibodies, antineoplastic

L01XC27 olaratumab